FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361284013> ?p ?o ?g. }

• W4361284013 abstract "The effectiveness of nitric oxide (NO) in reducing the risk of bronchopulmonary dysplasia (BPD) remains debatable. In this study, we performed a meta-analysis to guide clinical decision-making regarding the significance of inhaled NO (iNO) on the potential occurrence and outcomes of BPD in premature infants.Data from clinical randomized controlled trials (RCTs) published in PubMed, Embase, Cochrane Library, Wanfang, China National Knowledge Infrastructure (CNKI) and Chinese Scientific Journal Database VIP databases for premature infants were searched from inception to March 2022. Review Manager 5.3 statistical software was used for heterogeneity analysis.Of the 905 studies retrieved, 11 RCTs met the screening criteria of this study. Our analysis showed that the iNO group was associated with a significantly lower incidence of BPD than the control group (relative risk [RR] = 0.91, 95% confidence interval (CI) 0.85-0.97, P = 0.006). We also observed no significant difference in the incidence of BPD between the two groups at the initial dose of 5 ppm (ppm) (P = 0.09) but those treated with 10 ppm iNO had a significantly lower incidence of BPD (RR = 0.90, 95%CI 0.81-0.99, P = 0.03). However, it should be noted that although the iNO group had an increased risk for necrotizing enterocolitis (NEC) (RR = 1.33, 95%CI 1.04-1.71, P = 0.03), cases treated with an initial dose of 10 ppm revealed no significant difference in the incidence of NEC compared with the control group (P = 0.41), while those treated with an initial dosage of 5 ppm of iNO had a significantly greater NEC rates than the control group (RR = 1.41, 95%CI 1.03-1.91, P = 0.03). Further, we observed no statistically significant differences in the incidence of in-hospital mortality, intraventricular hemorrhage (IVH) (Grade 3/4) or periventricular leukomalacia (PVL) and pulmonary hemorrhage (PH) between the two treatment groups.This meta-analysis of RCTs showed that iNO at an initial dosage of 10 ppm seemed more effective in reducing the risk of BPD than conventional treatment and iNO at an initial dosage of 5 ppm in preterm infants at a gestational age of ≤34 weeks who required respiratory support. However, the incidence of in-hospital mortality and adverse events between the overall iNO group and Control were similar." @default.
• W4361284013 created "2023-03-31" @default.
• W4361284013 creator A5070420565 @default.
• W4361284013 creator A5081842390 @default.
• W4361284013 creator A5083679560 @default.
• W4361284013 date "2023-03-29" @default.
• W4361284013 modified "2023-10-09" @default.
• W4361284013 title "Inhaled nitric oxide in premature infants for preventing bronchopulmonary dysplasia: a meta-analysis" @default.
• W4361284013 cites W1572297871 @default.
• W4361284013 cites W1597886774 @default.
• W4361284013 cites W1968301465 @default.
• W4361284013 cites W1970723735 @default.
• W4361284013 cites W1973885213 @default.
• W4361284013 cites W1992134746 @default.
• W4361284013 cites W2003276028 @default.
• W4361284013 cites W2009383132 @default.
• W4361284013 cites W2013739133 @default.
• W4361284013 cites W2037417765 @default.
• W4361284013 cites W2039420762 @default.
• W4361284013 cites W2052940703 @default.
• W4361284013 cites W2055274506 @default.
• W4361284013 cites W2067799096 @default.
• W4361284013 cites W2111575740 @default.
• W4361284013 cites W2114574443 @default.
• W4361284013 cites W2120415735 @default.
• W4361284013 cites W2144821608 @default.
• W4361284013 cites W2159943126 @default.
• W4361284013 cites W2164964624 @default.
• W4361284013 cites W2167171499 @default.
• W4361284013 cites W2191597877 @default.
• W4361284013 cites W2238405015 @default.
• W4361284013 cites W2261463650 @default.
• W4361284013 cites W2757994388 @default.
• W4361284013 cites W2764260555 @default.
• W4361284013 cites W2792811894 @default.
• W4361284013 cites W2978795816 @default.
• W4361284013 cites W3136029643 @default.
• W4361284013 cites W3154871284 @default.
• W4361284013 cites W3217169965 @default.
• W4361284013 cites W4200076014 @default.
• W4361284013 cites W4206514196 @default.
• W4361284013 cites W4248251600 @default.
• W4361284013 cites W4255256525 @default.
• W4361284013 cites W4361868993 @default.
• W4361284013 doi "https://doi.org/10.1186/s12887-023-03923-4" @default.
• W4361284013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36991371" @default.
• W4361284013 hasPublicationYear "2023" @default.
• W4361284013 type Work @default.
• W4361284013 citedByCount "2" @default.
• W4361284013 countsByYear W43612840132023 @default.
• W4361284013 crossrefType "journal-article" @default.
• W4361284013 hasAuthorship W4361284013A5070420565 @default.
• W4361284013 hasAuthorship W4361284013A5081842390 @default.
• W4361284013 hasAuthorship W4361284013A5083679560 @default.
• W4361284013 hasBestOaLocation W43612840131 @default.
• W4361284013 hasConcept C119423318 @default.
• W4361284013 hasConcept C120665830 @default.
• W4361284013 hasConcept C121332964 @default.
• W4361284013 hasConcept C126322002 @default.
• W4361284013 hasConcept C168563851 @default.
• W4361284013 hasConcept C187212893 @default.
• W4361284013 hasConcept C2776478404 @default.
• W4361284013 hasConcept C2778376644 @default.
• W4361284013 hasConcept C2778721537 @default.
• W4361284013 hasConcept C2779234561 @default.
• W4361284013 hasConcept C2779303187 @default.
• W4361284013 hasConcept C44249647 @default.
• W4361284013 hasConcept C54355233 @default.
• W4361284013 hasConcept C61511704 @default.
• W4361284013 hasConcept C65409693 @default.
• W4361284013 hasConcept C71924100 @default.
• W4361284013 hasConcept C82789193 @default.
• W4361284013 hasConcept C86803240 @default.
• W4361284013 hasConcept C95190672 @default.
• W4361284013 hasConceptScore W4361284013C119423318 @default.
• W4361284013 hasConceptScore W4361284013C120665830 @default.
• W4361284013 hasConceptScore W4361284013C121332964 @default.
• W4361284013 hasConceptScore W4361284013C126322002 @default.
• W4361284013 hasConceptScore W4361284013C168563851 @default.
• W4361284013 hasConceptScore W4361284013C187212893 @default.
• W4361284013 hasConceptScore W4361284013C2776478404 @default.
• W4361284013 hasConceptScore W4361284013C2778376644 @default.
• W4361284013 hasConceptScore W4361284013C2778721537 @default.
• W4361284013 hasConceptScore W4361284013C2779234561 @default.
• W4361284013 hasConceptScore W4361284013C2779303187 @default.
• W4361284013 hasConceptScore W4361284013C44249647 @default.
• W4361284013 hasConceptScore W4361284013C54355233 @default.
• W4361284013 hasConceptScore W4361284013C61511704 @default.
• W4361284013 hasConceptScore W4361284013C65409693 @default.
• W4361284013 hasConceptScore W4361284013C71924100 @default.
• W4361284013 hasConceptScore W4361284013C82789193 @default.
• W4361284013 hasConceptScore W4361284013C86803240 @default.
• W4361284013 hasConceptScore W4361284013C95190672 @default.
• W4361284013 hasIssue "1" @default.
• W4361284013 hasLocation W43612840131 @default.
• W4361284013 hasLocation W43612840132 @default.
• W4361284013 hasLocation W43612840133 @default.
• W4361284013 hasLocation W43612840134 @default.
• W4361284013 hasOpenAccess W4361284013 @default.
• W4361284013 hasPrimaryLocation W43612840131 @default.

• next